NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 130 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.07 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $128,239 | 0.0% | 31,431 | 0.0% | 0.00% | – |
| Q1 2023 | $128,239 | -18.7% | 31,431 | 0.0% | 0.00% | – |
| Q4 2022 | $157,783 | -100.0% | 31,431 | +2.2% | 0.00% | – |
| Q3 2022 | $402,432,000 | -9.4% | 30,767 | -11.2% | 0.00% | – |
| Q2 2022 | $444,379,000 | +56.4% | 34,663 | +86.1% | 0.00% | – |
| Q1 2022 | $284,093,000 | -13.9% | 18,629 | 0.0% | 0.00% | – |
| Q4 2021 | $329,919,000 | -37.1% | 18,629 | -25.3% | 0.00% | – |
| Q3 2021 | $524,344,000 | +160.9% | 24,945 | +144.8% | 0.00% | – |
| Q2 2021 | $200,967,000 | – | 10,191 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 18,136,735 | $232,513,000 | 49.48% |
| Ponoi II Management, LLC | 1,298,908 | $16,652,000 | 45.25% |
| Ponoi Management, LLC | 1,298,908 | $16,652,000 | 26.29% |
| Euclidean Capital LLC | 746,674 | $9,572,000 | 8.14% |
| StepStone Group LP | 1,573,357 | $20,170,000 | 2.16% |
| First Light Asset Management, LLC | 1,135,884 | $14,562,000 | 1.69% |
| Lexington Partners L.P. | 110,428 | $1,416,000 | 0.73% |
| Rubric Capital Management LP | 797,588 | $10,225,000 | 0.54% |
| Boxer Capital, LLC | 500,000 | $6,410,000 | 0.41% |
| DAFNA Capital Management LLC | 107,653 | $1,380,000 | 0.38% |